Why Some Dermatologists Are Adopting JAKs for Uncontrolled Moderate-to-Severe Atopic Dermatitis
Sponsored by Pfizer Managing atopic dermatitis (AD), also known as eczema, remains a significant challenge for many patients and dermatologists. Despite the use of topical agents and systemic treatments such as biologics, many patients still experience …